KLK3 and prostate carcinoma: In addition, we found that mRNA expression differed between prostate cancer and non-cancer groups in the PSA range of 4–20 ng/ml, and constructed a comprehensive model of urinary exosomal mRNAs for the diagnosis of prostate cancer.